JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Blackrock
BLK
$164B
| $1.56B | 0.19% |
2,332,142
-683,391
| -23% | -$481M |
2013 Q2
39 quarters
|
|
127
Costco
COST
$408B
| $1.48B | 0.18% |
2,985,318
+574,251
| +24% | +$282M |
2013 Q2
39 quarters
|
|
128
Walmart Inc
WMT
$827B
| $1.48B | 0.18% |
30,097,089
-2,966,760
| -9% | -$141M |
2013 Q2
39 quarters
|
|
129
Baker Hughes
BKR
$55.6B
| $1.48B | 0.18% |
51,167,608
+622,291
| +1% | +$18.8M |
2017 Q3
22 quarters
|
|
130
Pfizer
PFE
$158B
| $1.46B | 0.18% |
35,729,792
-13,380,482
| -27% | -$578M |
2013 Q2
39 quarters
|
|
131
Public Service Enterprise Group
PEG
$33.9B
| $1.45B | 0.18% |
23,276,991
+3,635,609
| +19% | +$220M |
2013 Q2
39 quarters
|
|
132
Amgen
AMGN
$218B
| $1.45B | 0.18% |
6,008,770
-2,166,154
| -26% | -$532M |
2013 Q2
39 quarters
|
|
133
JPMorgan Equity Premium Income ETF
JEPI
$45.2B
| $1.45B | 0.18% |
26,574,339
+7,144,154
| +37% | +$388M |
2020 Q2
11 quarters
|
|
134
ASML
ASML
$717B
| $1.44B | 0.18% |
2,110,648
-77,850
| -4% | -$50M |
2013 Q2
39 quarters
|
|
135
Abbott
ABT
$169B
| $1.43B | 0.17% |
14,163,253
+1,117,373
| +9% | +$118M |
2013 Q2
39 quarters
|
|
136
Truist Financial
TFC
$56.7B
| $1.42B | 0.17% |
41,689,798
-19,343,718
| -32% | -$844M |
2013 Q2
39 quarters
|
|
137
PUT
iShares Morningstar Value ETF
ILCV
$1.32B
| $1.4B | 0.17% |
18,553,800
+6,985,600
| +60% | +$449M |
2014 Q3
34 quarters
|
|
138
iShares Russell 1000 Value ETF
IWD
$81.4B
| $1.38B | 0.17% |
9,088,950
-5,116,375
| -36% | -$790M |
2013 Q2
39 quarters
|
|
139
Capital One
COF
$119B
| $1.36B | 0.17% |
14,123,739
+1,493,125
| +12% | +$156M |
2013 Q2
39 quarters
|
|
140
Chubb
CB
$128B
| $1.33B | 0.16% |
6,858,723
-171,218
| -2% | -$36M |
2013 Q2
39 quarters
|
|
141
CALL
Tesla
TSLA
$1.46T
| $1.29B | 0.16% |
6,204,500
+141,400
| +2% | +$24.7M |
2014 Q3
34 quarters
|
|
142
Monster Beverage
MNST
$84.1B
| $1.29B | 0.16% |
47,661,700
+2,448,608
| +5% | +$62.8M |
2013 Q2
39 quarters
|
|
143
iShares 1-3 Year Treasury Bond ETF
SHY
$26.2B
| $1.27B | 0.15% |
15,465,562
+209,870
| +1% | +$17.1M |
2013 Q2
39 quarters
|
|
144
Infosys
INFY
$44.7B
| $1.27B | 0.15% |
72,618,957
+4,557,724
| +7% | +$82.9M |
2013 Q2
39 quarters
|
|
145
iShares Core MSCI Emerging Markets ETF
IEMG
$163B
| $1.26B | 0.15% |
25,854,366
+7,512,406
| +41% | +$369M |
2014 Q1
36 quarters
|
|
146
Vanguard Short-Term Treasury ETF
VGSH
$34.4B
| $1.26B | 0.15% |
21,506,150
+502,409
| +2% | +$29.2M |
2018 Q3
18 quarters
|
|
147
DexCom
DXCM
$32.2B
| $1.25B | 0.15% |
10,764,828
+117,732
| +1% | +$13.2M |
2015 Q3
30 quarters
|
|
148
Workday
WDAY
$44.9B
| $1.23B | 0.15% |
5,951,816
+2,215,883
| +59% | +$403M |
2013 Q2
39 quarters
|
|
149
PNC Financial Services
PNC
$88.2B
| $1.23B | 0.15% |
9,670,022
+400,814
| +4% | +$60.4M |
2013 Q2
39 quarters
|
|
150
McKesson
MCK
$105B
| $1.22B | 0.15% |
3,428,306
-1,886,753
| -35% | -$682M |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.